Indivior Pharmaceuticals (INDV) Other Operating Expenses (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Other Operating Expenses of -$1.0 million for Q1 2026, little changed year-over-year from -$1.0 million in Q1 2025, and up 50.0% quarter-over-quarter from -$2.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Other Operating Expenses (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$1.0 million for Q1 2026.
- In Q1 2026, Other Operating Expenses changed 0.0% year-over-year to -$1.0 million; the TTM figure through Mar 2026 stood at -$3.0 million (up 98.47% YoY), while the FY2025 annual figure was -$3.0 million, up 98.46% from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$1.0 million, up from -$2.0 million in the prior quarter.
- The five-year high for Other Operating Expenses was $1.0 million in Q4 2024, with the low at -$160.0 million in Q2 2024.
- The 3-year median for Other Operating Expenses is -$1.5 million (2025), against an average of -$33.2 million.
- The sharpest annual moves came in 2025 and 2026: Other Operating Expenses plunged 300.0% in 2025, then changed 0.0% in 2026.
- Indivior Pharmaceuticals' Other Operating Expenses stood at $1.0 million in 2024, then slumped by 300.0% to -$2.0 million in 2025, then jumped by 50.0% to -$1.0 million in 2026.
- Business Quant data shows INDV's Other Operating Expenses at -$1.0 million in Q1 2026, -$2.0 million in Q4 2025, and -$1.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Indivior Pharmaceuticals | 4.51 Bn | 4.29 Bn | 294.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.00 Mn |
| Dec 31, 2025 | -2.00 Mn |
| Mar 31, 2025 | -1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | -36.00 Mn |
| Jun 30, 2024 | -160.00 Mn |